Purpose of review With the realization that lipid droplets are not merely inert fat storage organelles, but highly dynamic and actively involved in cellular lipid homeostasis, there has been an increased interest in lipid droplet biology. Recent studies have begun to unravel the roles that lipid dropletss play in cellular physiology and provide insights into the mechanisms by which lipid droplets contribute to cellular homeostasis. This review provides a summary of these recent publications on lipid droplet metabolism.
INTRODUCTION
As cytoplasmic organelles, lipid droplets are composed of a neutral lipid core containing triacylglycerol (TAG) and/or cholesterol esters coated with a phospholipid monolayer. Depending on the cell type, lipid droplet sizes range from less than 1 mm in fibroblasts to more than 50 mm in primary adipocytes. These lipid droplets, originally considered to be inert fat depots in cells, have now been shown to be highly dynamic and to be actively involved in cellular lipid accumulation, storage, and metabolism, directly contributing to cellular physiology. As the discovery that perilipin (now named PLIN1) coats the surface of lipid droplets, numerous proteins have been shown to associate with lipid droplets and to change under different physiological conditions. These proteins serve as lipid droplet gatekeepers as well as messengers interacting with cytosolic proteins and other organelles controlling cellular lipid homeostasis. Here we briefly review some of the most recent findings published within the past year related to lipid droplet metabolism.
PERILIPIN AND CELL DEATH-INDUCING DFF45-LIKE EFFECTOR PROTEINS
There are many proteins reported to be associated with lipid droplets. Two families of lipid dropletassociated proteins that are of particular interest are the perilipin (PLIN) and cell death-inducing DFF45-like effector (CIDE) protein families. Although PLIN1 was the first protein identified to be associated with lipid droplets, the PLIN family has expanded to include perilipin (PLIN1), ADRPhave different preferences for association with TAG or cholesteryl esters. PLIN1a, PLIN2, and PLIN5 are more prominently found with cellular TAG loading, whereas PLIN1c and PLIN4 are enhanced by cellular cholesterol loading [1] .
PLIN1 is highly expressed in white adipocytes and is actively involved in the regulation of lipolysis through changes of its phosphorylation status and its interaction with lipases [hormone-sensitive lipase (HSL)] and lipase activators [CGI-58 for adipose triglyceride lipase (ATGL)]. Recent observations have shown that PLIN1 also interacts with and activates fat-specific protein of 27 kDa (FSP27) and promotes the enlargement of lipid droplets, leading to the formation of large lipid droplets [2, 3] .
PLIN2 is ubiquitously expressed and interacts with lipid droplets via both its N and C-terminal domains. A recent study employing fluorescence resonance energy transfer (FRET) showed that PLIN2 interacts with lipid droplet surface lipids such as phosphatidylcholine, cholesterol, sphingomyelin, and stearic acid with a molecular distance approximately 44-57 Å [4 && ], indicating the interactions were occurring within the monolayer or at the monolayer surface. Overexpression of PLIN2 increases cellular phospholipid content, in addition to TAG and cholesteryl esters, suggesting PLIN2 may play a role in increasing lipid droplet membrane size to accommodate droplet expansion during lipid accumulation. PLIN2 has been reported to interact with ATGL in resting and postcontraction muscle, with a 21% decrease in the interaction observed after contraction [5] . Meanwhile PLIN2-associated lipid droplets were preferentially depleted during moderate-intensity endurance-type exercise [6] . Although the discovery of the presence of a truncated PLIN2 in the original PLIN2-deficient mice complicated the interpretation of the results, recent studies using antisense oligonucleotides (ASO) to silence PLIN2 confirmed that downregulation of PLIN2 could be beneficial to combat fat accumulation in the liver [7] without cholesterol-induced toxicity to macrophages [8] . Subsequent generation of conditional PLIN2 knockout mice showed that the absence of PLIN2 leads to resistance to high-fat diet-induced obesity through modulating food intake and locomotor activity [9] . Similarly, silencing PLIN2 was shown to effectively attenuate the growth of tumor cells [10] . In contrast to these potentially beneficial effects of reducing PLIN2 expression, higher PLIN2 levels have been suggested to be protective against lipotoxicity and insulin resistance in skeletal muscle [11] . Most recently, a missense polymorphism of PLIN2, Ser251Pro, was described in humans that leads to structural changes in the protein resulting in increased cellular lipid accumulation, increased number of small lipid droplets and decreased lipolysis, along with a decrease in plasma triglyceride concentrations. This is the first example in which a polymorphism in PLIN2 has been shown to be a functional variant that is associated with plasma very low density lipoprotein (VLDL) and triglyceride levels [12 && ]. The impact of this polymorphism on human metabolic diseases remains to be explored.
PLIN3 is widely expressed in hepatocytes, enterocytes, and macrophages, as well as testes [13] , and is increased in response to lipid loading. Structural analysis shows a spatial separation of the N and C-terminal regions in monomeric human PLIN3 by its a/b domain, indicating the existence of two distinct 'functional modules' and may explain the protein's unique dual functions: involvement in mannose-6-phosphate receptor recycling and in lipid biogenesis [14] . ASO-silencing studies show that PLIN3 affects hepatic lipid and glucose metabolism and may be a target for the treatment of nonalcoholic fatty liver and related metabolic disorders [15] .
Primarily expressed in oxidative tissues, PLIN5, the newest member of the family, was shown to localize to both lipid droplets and mitochondria in muscle cells [16] . PLIN5 has been shown to increase lipid accumulation, to enhance fatty acid oxidation through peroxisome proliferator-activated receptor (PPAR)-a-dependent pathways in the liver [17] , to sequester fatty acid from excessive oxidation and to protect the heart from oxidative stress [18] . Previously reported cytosolic pools of PLIN5 are KEY POINTS Different PLINs have different preferences for associating with TAG or cholesteryl esters, different tissue distributions, and each contributing to cellular lipid metabolism in its unique way. CIDE family members are not only involved in lipid droplet expansion, they are also involved in the cellular response to stress and lipid secretion.
Lipid droplets are constantly in an active cycle of lipolysis and re-esterification (during which microlipid droplets are formed), with TAG synthesis occurring in the endoplasmic reticulum (ER) and on lipid droplets, and with TAG transferring between lipid droplets during lipid droplet fusion and lipid droplet enlargement.
Lipid droplets interact with ER and mitochondria for lipid synthesis and metabolism. Multiple interacting protein pairs have been identified (FATP1 and DGAT2 for TAG synthesis; UBXD8 and ATGL for TAG turnover; PLIN5 facilitates the interaction of lipid droplets and mitochondria for fatty acid oxidation).
actually bound to structures of high-density lipid droplets [19] and could represent nascent intracellular sites for lipid accumulation, and potential shifts to larger lipid droplets upon lipid loading. These latter findings raise the possible involvement of PLIN5 during lipid trafficking from very small lipid droplets to larger lipid droplets. PLIN5 was also shown to be one of the few genes that were differentially expressed in brown adipose tissue (BAT) as compared to white adipose tissue (WAT). Interestingly, PLIN5 is significantly induced in WAT (gonadal and subcutaneous) following cold challenge as the WAT undergoes a 'browning' process [20] , again suggesting that PLIN5 might have an important role in BAT metabolism through its involvement in fatty acid oxidation.
CIDE protein family (CIDEA, CIDEB, and CIDEC, also known as FSP27), has been shown to reside on lipid droplets and on the ER, to be involved in lipid droplet fusion in adipocytes, VLDL lipidation, and maturation in the liver. CIDEA was found to be a downstream target of FoxO1 and involved in the signaling for ß-cell apoptosis induced by lipotoxicity [21] . CIDEB was observed to be associated with the Golgi apparatus, with decreased mature VLDL found in the Golgi of CIDEB À/À mice livers, thus linking CIDEB with VLDL formation. Further studies showed that CIDEB and PLIN2 might exert opposing effects on VLDL lipidation in hepatocytes [22] . FSP27 and CIDEA were shown to be enriched at lipid droplet-lipid droplet contact sites and the CIDE proteins promoted lipid transfer from smaller lipid droplets to larger lipid droplets [23] . Recently, FSP27 was shown to interact with PLIN1 through its CIDE-N domain, leading to increased lipid transfer activity [2] . Meanwhile, we have shown that FSP27 forms a physical interaction with nuclear factor of activated T cells 5 (NFAT5) at the lipid droplet surface and this interaction modulates the cellular response to osmotic stress by preventing NFAT5 from translocating to the nucleus and activating its downstream targets [24 && ]. In addition, Li's group has shown that both CIDEA and CIDEC are detected in the nucleus and that CIDEA can act as a transcriptional coactivator for C/EBPb for controlling lipid secretion by modulating the expression of xanthine oxidoreductase in mammary epithelial cells [25] .
In summary, lipid droplet-associated proteins are vital constituents and actively involved in control of lipid droplet homeostasis.
LIPOLYSIS AND LIPID DROPLET REMODELING
G0/G1 switch gene-2 (G0S2) has recently been implicated in regulating lipolysis through ATGL.
G0S2 was shown to inhibit activity while also anchoring ATGL to the lipid droplet, in contrast to CGI-58 that activates ATGL [26] . In poorly controlled type-2 diabetic patients, there is a significant decrease in mRNA of both PLIN1 and G0S2, which may contribute to elevated lipolysis and plasma-free fatty acids in diabetes [27] . Chronic stimulation of lipolysis induces the appearance of hundreds of micro-lipid droplets (<1 mm in diameter). Initial studies showed that there were four proteins associated with micro-lipid droplets, namely PLIN1a, PLIN2, PLIN4, and CGI-58. Originally, it was suggested that these micro-lipid droplets were formed from fragmentation of lipid droplets upon lipolytic stimulation. Recently, several investigators have shown that these micro-lipid droplets are actually formed from re-esterification of excess fatty acid released during lipolysis and quickly become sites of active lipolysis by recruiting ATGL and HSL to the micro-lipid droplets [28,29 && ,30] . When lipolysis is terminated and cells return to lipogenesis and lipid accumulation, these micro-lipid droplets can fuse and grow to macro-lipid droplets through a mechanism involving microtubules.
LIPID DROPLETS AND ORGANELLAR INTERACTIONS
Lipid droplets have been seen to interact with other organelles, such as the ER and mitochondria, by merging fluorescent images and by electron microscopy. The formation of lipid droplets is thought to occur at the ER; however, little is known about the specifics of how these lipid droplets form or how they expand. Recent work has looked into proteins that may be involved in these processes. A complex between resident ER protein FATP1 and lipid droplet protein DGAT2 was found that facilitated lipid droplet expansion, which was absent in catalytically dead mutants of FATP1 or DGAT2 [31 && ]. This interaction may provide a physical and functional link between the ER and lipid droplets. Among other ER proteins, members of the small guanosine-triphosphatase family, Rab proteins, have been suggested to function in lipid droplet trafficking within the ER and lipid droplet formation. A systematic approach found that many Rabs were able to regulate the dynamics of lipid droplets, with Rab32 affecting lipid storage through its effects on autophagy [32] .
In addition to the role of the ER as the putative site for lipid droplet formation and expansion, ER stress has an effect on lipid droplet physiology. ER stress was found to promote hepatic lipogenic transactivators, lipid droplet promoting proteins, and enzymes involved in de-novo lipogenesis, all of which have potentially important implications for the development of metabolic disease and diabetes [33] . In addition to lipid droplet promotion, ER stress may result in an increase of lipolysis. In differentiated adipocytes, ER stress led to an activation of cyclic adenosine monophosphate/protein kinase A and extracellular signal-regulated kinases 1/2, leading to phosphorylation of PLIN1 and phosphorylation and translocation of HSL [34 && ], resulting in an increased fatty acid efflux and consequences such as lipotoxicity and insulin resistance.
The intimate relationship of the ER and lipid droplet formation involves the participation of many proteins and the sharing of many processes. Several proteins and complexes have recently been found to function in regulating neutral lipid storage by mechanisms involving ER-associated degradation (ERAD). A recent study has identified Aup1 in maintaining cholesterol homeostasis by interactions with ERAD and facilitating binding of gp78 and Trc8 to ubiquitin-conjugating enzyme (Ubc7) at the lipid droplet surface [35] . Aup1, a highly conserved protein, was found to have a single domain that allowed for insertion into the ER as well as into lipid droplets [36] . Resident ER protein, ubiquitin regulatory X (UBX)-domain containing protein (Ubx2), which selectively transports misfolded proteins for ERAD, was found to be crucial in lipid droplets maintenance, with deletion leading to a 50% decrease in intracellular TAG accumulation [37] . Similarly, UBXD8 was found to bind to ATGL, thus contributing to lipid droplet turnover and maintaining lipid droplet size, as well as providing an important mechanism for regulating energy balance [38 && ]. In addition to the ER, lipid droplets are known to interact with mitochondria for fatty acid metabolism or steroidogenesis. Recent studies show that PLIN5 is highly expressed in muscle tissue, being expressed on both lipid droplets and mitochondria, and involved in directing fatty acid transfer from lipid droplets to mitochondria for fatty acid oxidation [39] . Exercise was found to increase transcriptional coactivator PPAR-g coactivator-1a, leading to an increase in genes involved in lipid droplet assembly and mobilization and mitochondrial remodeling, including PLIN5 [40] . Retinyl esters, the stored form of retinal, accumulate within lipid droplets and have been observed to utilize a complex between the ER, lipid droplets, and mitochondria for synthesis and metabolism. Retinol dehydrogenase, Rdh10, is localized to mitochondria and the mitochondria-associated membrane of the ER, but translocates to lipid droplets during retinyl acyl ester biosynthesis, co-localizing with cellular retinol-binding protein 1 and lecithin retinol acyltransferase 1, an ER protein [41] . Activation of hepatic stellate cells into myofibroblasts leads to a replacement of retinyl esters by polyunsaturated fatty acids in lipid droplets, suggesting a dynamic and regulated process at the lipid droplet [42] .
LIPID DROPLETS SYNTHESIS AND FUSION
Lipid droplets are thought to grow by TAG synthesis in the ER or by the fusion of smaller lipid droplet proteins. Although conventional dogma is that de-novo TAG synthesis occurs in the ER, a recent study has challenged this paradigm. Wilfling et al. [43 && ] described the translocation of TAG synthetic enzymes GPAT4, AGPAT3, and DGAT2 to the lipid droplet. These proteins were capable of catalyzing the synthesis of TAG at the lipid droplet, leading to an increase in lipid droplet size. This provides a mechanism, in addition to lipid droplet fusion, for the growth of lipid droplets and a mechanism for lipid droplet growth in cells that lack components involved in lipid droplet fusion, such as FSP27 and PLIN1. It will be interesting to determine in cells that have FSP27 and PLIN1, such as adipocytes, the percentage of lipid droplet growth due to TAG synthesis at the lipid droplet or to lipid droplet fusion. In addition to TAG synthesis, lipid droplet growth can be observed by inhibition of lipolysis. PLIN5 was found to negatively regulate lipolysis and fatty acid oxidation, contributing to TAG accumulation [17] .
Smaller lipid droplets can fuse to create larger lipid droplets, which is mediated by FSP27 in adipocytes. Recent studies have found that a functional cooperation occurs between FSP27 and PLIN1, which was required for efficient lipid droplet growth and unilocular formation in adipocytes [2] [3] . In addition to FSP27, SNAP23, a member of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor family, is important in the fusion of lipid droplets. A recent study found that g-synuclein might deliver SNAP23 to lipid droplets and prevent lipolysis by sequestering ATGL [44] .
The expansion, growth, and turnover of lipid droplets constitute dynamic processes, requiring various signals that maintain or change the disposition of lipid droplets. Several factors have been shown to influence the rate of lipid droplet accumulation and fusion. An increase in squalene levels, a hydrocarbon that is a biochemical precursor to cholesterol, was found not to have a deleterious effect on lipid particles and may modulate membrane fluidity [45] . Further studies have shown that an increase in squalene levels triggers an aggregation of lipid droplets, which may preclude lipid droplet fusion [46] . The role of squalene as a promoter of lipid droplet expansion deserves further analysis.
Macroautophagy, an intracellular degradation system, may also play a role in maintaining lipid droplet size. Autophagy-related (Atg) protein was found to be present on autophagic membranes as well as lipid droplets and depletion of Atg2 led to a clustering of enlarged lipid droplets [47] .
CONCLUSION
Many new insights into lipid droplet physiology have emerged recently (as illustrated in Fig. 1 ). PLIN and CIDE family members have been found to participate in new ways in lipid homeostasis in addition to their involvement in fat storage. Studies have revealed that TAG synthetic enzymes localize directly on lipid droplets, providing TAG for lipid droplet enlargement. Lipid droplets interact with ER and mitochondria to facilitate lipid transfer, lipid droplet expansion, and metabolism. Improved microscopic techniques have allowed observations showing that lipid droplets are in an active cycle of lipolysis and re-esterification to form micro-lipid droplets, that TAG synthesis occurs in the ER and on lipid droplets, and that TAG transfers between lipid droplets during lipid droplet fusion. Lipid droplets continue to be shown to be involved in various aspects of cellular physiology and these studies highlight the functional significance of lipid droplets in cellular lipid metabolism.
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